» Articles » PMID: 20188203

Autophagy, a Guardian Against Neurodegeneration

Overview
Date 2010 Mar 2
PMID 20188203
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is an intracellular degradation process responsible for the clearance of most long-lived proteins and organelles. Cytoplasmic components are enclosed by double-membrane autophagosomes, which subsequently fuse with lysosomes for degradation. Autophagy dysfunction may contribute to the pathology of various neurodegenerative disorders, which manifest abnormal protein accumulation. As autophagy induction enhances the clearance of aggregate-prone intracytoplasmic proteins that cause neurodegeneration (like mutant huntingtin, tau and ataxin 3) and confers cytoprotective roles in cell and animal models, upregulating autophagy may be a tractable therapeutic strategy for diseases caused by such proteins. Here, we will review the molecular machinery of autophagy and its role in neurodegenerative diseases. Drugs and associated signalling pathways that may be targeted for pharmacological induction of autophagy will also be discussed.

Citing Articles

The role of lipid metabolism in cognitive impairment.

Xu M, Wang L, Meng Y, Kang G, Jiang Q, Yan T Arq Neuropsiquiatr. 2025; 83(1):1-13.

PMID: 39814004 PMC: 11735072. DOI: 10.1055/s-0044-1792097.


Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.

Pluta R, Bogucka-Kocka A, Bogucki J, Kocki J, Czuczwar S J Alzheimers Dis. 2024; 99(4):1375-1383.

PMID: 38759019 PMC: 11191440. DOI: 10.3233/JAD-240401.


ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice.

Li W, Ali T, He K, Zheng C, Li N, Yu Z J Cell Mol Med. 2024; 28(7):e18160.

PMID: 38506067 PMC: 10951871. DOI: 10.1111/jcmm.18160.


Possible Therapeutic Intervention Strategies for COVID-19 by Manipulating the Cellular Proteostasis Network.

Ali M, Rajurkar J, Majumder P, Jha M, Sarkar R, Mapa K Adv Exp Med Biol. 2022; 1352:125-147.

PMID: 35132598 DOI: 10.1007/978-3-030-85109-5_8.


Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy.

Shaikh S, Ahmad K, Ahmad S, Lee E, Lim J, Ali Beg M Oxid Med Cell Longev. 2021; 2021:6347792.

PMID: 34557265 PMC: 8455192. DOI: 10.1155/2021/6347792.


References
1.
Sarkar S, Rubinsztein D . Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. Autophagy. 2006; 2(2):132-4. DOI: 10.4161/auto.2387. View

2.
Dierks T, Schmidt B, Borissenko L, Peng J, Preusser A, Mariappan M . Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell. 2003; 113(4):435-44. DOI: 10.1016/s0092-8674(03)00347-7. View

3.
Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung R . Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002; 4(9):699-704. DOI: 10.1038/ncb847. View

4.
Lee V, Chapman J . Sirolimus: its role in nephrology. Nephrology (Carlton). 2005; 10(6):606-14. DOI: 10.1111/j.1440-1797.2005.00493.x. View

5.
Kim D, Sarbassov D, Ali S, King J, Latek R, Erdjument-Bromage H . mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002; 110(2):163-75. DOI: 10.1016/s0092-8674(02)00808-5. View